一鸣食品(605179) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 654,136,578.47, representing a year-on-year increase of 1.75% compared to CNY 642,866,354.89 in the same period last year[4] - Net profit attributable to shareholders increased by 28.38% to CNY 13,306,745.84 from CNY 10,365,134.43 year-on-year[4] - The net profit after deducting non-recurring gains and losses rose by 47.37% to CNY 14,773,372.25, up from CNY 10,024,355.15 in the previous year[4] - Basic earnings per share increased by 28.68% to CNY 0.0332 from CNY 0.0258 year-on-year[5] - Total operating revenue for Q1 2025 was approximately ¥654.14 million, an increase of 1.98% compared to ¥642.87 million in Q1 2024[18] - Net profit for Q1 2025 reached approximately ¥13.31 million, representing a 28.36% increase from ¥10.37 million in Q1 2024[19] - The total profit for Q1 2025 was approximately ¥17.65 million, an increase of 30.67% from ¥13.57 million in Q1 2024[19] Cash Flow and Assets - The net cash flow from operating activities decreased by 51.29% to CNY 53,176,183.50, down from CNY 109,173,269.04 in the same period last year[4] - Cash flow from operating activities for Q1 2025 was approximately ¥53.18 million, a decrease of 51.32% compared to ¥109.17 million in Q1 2024[21] - Cash and cash equivalents at the end of Q1 2025 totaled approximately ¥217.36 million, an increase from ¥164.03 million at the end of Q1 2024[22] - The company's cash and cash equivalents reached CNY 402,121,847.27, compared to CNY 373,235,302.92, showing an increase of approximately 7.73%[13] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,810,418,795.40, a 2.03% increase from CNY 2,754,515,418.51 at the end of the previous year[5] - As of March 31, 2025, the total assets of Zhejiang Yiming Food Co., Ltd. amounted to CNY 2,810,418,795.40, an increase from CNY 2,754,515,418.51 as of December 31, 2024, reflecting a growth of approximately 2.03%[13][15] - The total liabilities increased to CNY 1,701,066,335.75 from CNY 1,658,584,172.89, marking a rise of about 2.56%[15] - The company's current assets totaled CNY 823,953,524.39, up from CNY 735,056,945.57, indicating an increase of about 12.06%[13] - Accounts receivable rose to CNY 223,104,998.52 from CNY 177,302,817.69, representing a significant increase of approximately 25.83%[13] - The company's inventory stood at CNY 140,947,439.77, an increase from CNY 124,477,735.82, representing a growth of about 13.27%[13] - The total equity attributable to the parent company was CNY 1,109,352,459.65, up from CNY 1,095,931,245.62, reflecting a growth of about 1.22%[15] - Short-term borrowings increased to CNY 429,005,408.76 from CNY 374,484,072.19, indicating a rise of approximately 14.55%[15] Research and Development - The company's R&D expenses increased by 31.84%, primarily due to enhanced investment in dairy cow embryo technology[7] - Research and development expenses increased to approximately ¥12.99 million in Q1 2025, up from ¥9.85 million in Q1 2024, marking a growth of 31.67%[18] Government Support - The company received government subsidies amounting to CNY 3,471,007.83, which positively impacted its financial performance[6] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 38,681[9] Other Financial Metrics - The weighted average return on equity rose to 1.21%, an increase of 0.28 percentage points from the previous year[5] - The company reported a net cash inflow from financing activities of approximately ¥2.76 million in Q1 2025, compared to a net outflow of approximately ¥22.75 million in Q1 2024[22] - The company's sales expenses for Q1 2025 were approximately ¥117.37 million, slightly down from ¥118.80 million in Q1 2024[18] - The company did not report any net profit from subsidiaries in the current or previous period[20]